Cetuximab 500mg/100ml solution for infusion vials
NHS hospitals in England used £42,835,285 of indicative cost of Cetuximab 500mg/100ml solution for infusion vials in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 7.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Cetuximab 500mg/100ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Cetuximab 500mg/100ml solution for infusion vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Clatterbridge Cancer Centre Nhs Ft | £4,685,455 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,857,583 |
| The Christie Nhs Foundation Trust | £1,757,580 |
| Southend Univ Hosp Nhs Foundation Trust | £1,680,106 |
| The Royal Marsden Nhs Foundation Trust | £1,651,699 |
| Colchester Hospital University Nhs Ft | £1,245,988 |
| United Lincolnshire Hospitals Nhs Trust | £1,103,686 |
| Worcestershire Acute Hpls Nhs Trust | £1,045,714 |
| East And North Hertfordshire Nhs Trust | £1,015,348 |
| Barts Health Nhs Trust | £971,536 |
The primary-care picture
Cetuximab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Cetuximab medicine page.